We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Divalent Recombinant Immunotoxin Formed by a Disulfide Bond between the Extension Peptide Chains.
- Authors
Ji Hae Park; Hye Won Kwon; Hee Kyoung Chung; Ik-Hwan Kim; Kwangseog Ahn; Eui-Ju Choi; Pastan, Ira; MuHyeon Choe
- Abstract
Recombinant immunotoxin for the treatment of cancer was made by connecting toxins to 'carcinoma-specific' antibodies that selectively bind to cancer cells, then kills them without harming the normal cells. The divalent recombinant immunotoxin. [B3(Fab)-ext-PE38]2, is a derivative of B3(Fab)-PE38. [B3(Fab)-PE38 was made by fusing the Fab domain of the monoclonal antibody (MAb) B3 to PE38, a truncated mutant form of Pseudomonas exotoxin (PE). In this study, B3(Fab)-ext-PE38 was constructed, which has the hinge region of the B3(Fab)-PE38 extended with the peptide extension, G4C(G4S)2, and connected to the C3 connector. The Cys residue of the extension peptide chain makes the disulfide bond between the two Fab domains. The extension sequence (ext) makes the dimerization of B3(Fab)-ext-PE38 easier to form the divalent immunotoxin, because it decreases the steric hindrance between the two PE38s. The constructed genes were expressed in E. coli as inclusion bodies. Polypeptides that were obtained from the inclusion body were refolded, and the active forms were purified. The ID50 values of the divalent molecule, [B3(Fab)-ext-PE38]2, were about 4 ng/ml on A431 cell lines, about 1 ng/ml on CRL1739 cell lines, and 5 ng/ml on MCF-7 cell lines. The [B3(Fab)-ext-PE38]2 showed about a 12-fold higher cytotoxicity on CRL1739 cell lines than B3(scFv)-PE40 did.
- Subjects
CANCER treatment; CELL culture; CELL lines; CANCER; IMMUNOGLOBULINS; MOLECULAR cloning; MONOCLONAL antibodies; CHEMICAL reactions; ANTIBODY-toxin conjugates
- Publication
Molecules & Cells (Springer Nature), 2001, Vol 12, Issue 3, p398
- ISSN
1016-8478
- Publication type
Article
- DOI
10.1016/s1016-8478(23)17114-7